•  
• Tweet
•  
•  
•        Print
•  
•        Email
•  
•         Track Keywords

"Allocators are increasing their investments into quantitative asset managers like Taaffeite who can demonstrate a unique edge and ability to generate consistent uncorrelated returns over an extended period of time," said Dr. Desmond Lun, Chief Executive Officer of Taaffeite. "Ronald's impressive experience in building financial and operational infrastructure will be an important component in broadening our business and global platform."

Prior to joining Taaffeite, Raymond served as Chief Operating Offering and Chief Compliance Officer of Blueshift Capital LLC., a commodity based long/short fund. Previously, he was Director of Operations at Vermillion Asset Management (acquired by The Carlyle Group), and Vice President of Operations at Dreman Value Management. Raymond holds a B.S. in Finance from Rutgers University.

"I look forward to contributing to Taaffeite's impressive growth and its desire to set a new standard in quantitative finance," said Ronald Raymond.

Since its 2012 launch, Taaffeite has demonstrated the ability to generate industry leading results by applying computational biology and artificial intelligence in a quantitative investment approach. TCM Global Index Fund (Growth) has annualized +16.50% for the first half of 2017 and generated +6.45% rate of return in June, as cited by BarclayHedge.